CenterStar Asset Management’s Pfizer PFE Stock Holding History

CenterStar Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,000	Closed	-$408K	–	375
2025 Q3	$408K	Buy	+16,000	New	+$395K	0.09%	191
2024 Q4	–	Sell	-22,500	Closed	-$651K	–	359
2024 Q3	$651K	Buy	+22,500	New	+$656K	0.13%	135
2023 Q2	–	Sell	-13,900	Closed	-$567K	–	362
2023 Q1	$567K	Buy	+13,900	New	+$600K	0.21%	93
2022 Q4	–	Hold	0	–	–	–	236
2022 Q3	–	Hold	0	–	-$683K	–	454
2022 Q2	–	Hold	0	–	–	–	147
2022 Q1	–	Hold	0	–	–	–	103
2021 Q3	–	Hold	0	–	-$589K	–	745
2021 Q2	–	Hold	0	–	–	–	215
2021 Q1	–	Hold	0	–	–	–	107
2020 Q1	–	Hold	0	–	-$11K	–	840
2019 Q4	–	Hold	0	–	–	–	342
2019 Q3	–	Hold	0	–	-$129K	–	552
2019 Q2	–	Hold	0	–	–	–	80
2019 Q1	–	Hold	0	–	-$2K	–	498
2018 Q4	–	Hold	0	–	–	–	453
2018 Q2	–	Hold	0	–	-$9K	–	1017
2018 Q1	–	Hold	0	–	–	–	857
2017 Q4	–	Hold	0	–	–	–	893

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CenterStar Asset Management's PFE Position: Q1 2026 in Review

CenterStar Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 9,156 shares — an estimated $244K sold.

CenterStar Asset Management first reported a position in PFE in Q2 2023 and held it in 2 quarters. The position peaked at $915K in Q2 2023. 2,963 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

CenterStar Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
CenterStar Asset Management sold 9,156 Pfizer shares in Q1 2026, an estimated $244K.
CenterStar Asset Management first reported a position in Pfizer in Q2 2023 and held it in 2 quarters.
CenterStar Asset Management's Pfizer position peaked at $915K in Q2 2023.
2,963 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CenterStar Asset Management's 13F filing for Q1 2026, filed 1 May 2026.